Tecartus 71287-0219
Generic: Brexucabtagene Autoleucel
Product NDC
71287-0219- Manufacturer
- Kite Pharma, Inc.
- Dosage Form
- Suspension
- Route
- Intravenous
- Product Type
- Cellular Therapy
- Marketing Start
- July 24, 2020
- Listing Expires
- December 31, 2027
- Application
- BLA125703
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brexucabtagene Autoleucel | 2000000 1/68mL |
Packaging Options(1)
1 BAG in 1 PACKAGE (71287-219-02) / 68 mL in 1 BAG (71287-219-01)